With this acquisition, Aesculap will also add Aragon’s Caiman advanced energy product line and will be a part of its endoscopic and open surgical instruments porfolio.

Aesculap president Chuck DiNardo said the Caiman’s articulating jaw design and proprietary Lektrafuse technology provide improved clinical benefits.

"This acquisition will widen the scope of our surgical instrument portfolio and enhance Aesculap’s line of products to improve patient care," DiNardo said.

Aragon president and CEO Roseanne Varner said this transaction will allow for increased distribution of the Caiman product line.